ES2437201T3 - Composiciones de geles tópicos - Google Patents

Composiciones de geles tópicos Download PDF

Info

Publication number
ES2437201T3
ES2437201T3 ES06736159.2T ES06736159T ES2437201T3 ES 2437201 T3 ES2437201 T3 ES 2437201T3 ES 06736159 T ES06736159 T ES 06736159T ES 2437201 T3 ES2437201 T3 ES 2437201T3
Authority
ES
Spain
Prior art keywords
composition
nsaid
compositions
viscosity
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06736159.2T
Other languages
English (en)
Spanish (es)
Inventor
Monique Spann-Wade
Anthony J. Ward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GREEN MONIQUE RENATA
ISW Group Inc
Original Assignee
GREEN MONIQUE RENATA
ISW Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/361,384 external-priority patent/US20070053984A1/en
Application filed by GREEN MONIQUE RENATA, ISW Group Inc filed Critical GREEN MONIQUE RENATA
Application granted granted Critical
Publication of ES2437201T3 publication Critical patent/ES2437201T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES06736159.2T 2005-03-03 2006-02-27 Composiciones de geles tópicos Active ES2437201T3 (es)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US65808405P 2005-03-03 2005-03-03
US658084P 2005-03-03
US68110205P 2005-05-13 2005-05-13
US681102P 2005-05-13
US69020105P 2005-06-14 2005-06-14
US690201P 2005-06-14
US361384 2006-02-24
US11/361,384 US20070053984A1 (en) 2005-03-03 2006-02-24 Topical gels compositions
PCT/US2006/006780 WO2006096360A1 (en) 2005-03-03 2006-02-27 Topical gels compositions

Publications (1)

Publication Number Publication Date
ES2437201T3 true ES2437201T3 (es) 2014-01-09

Family

ID=42334238

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06736159.2T Active ES2437201T3 (es) 2005-03-03 2006-02-27 Composiciones de geles tópicos

Country Status (10)

Country Link
EP (1) EP1858503B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008531693A (cg-RX-API-DMAC7.html)
KR (1) KR20080008321A (cg-RX-API-DMAC7.html)
AU (1) AU2006220964A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0608077A2 (cg-RX-API-DMAC7.html)
CA (1) CA2599968A1 (cg-RX-API-DMAC7.html)
ES (1) ES2437201T3 (cg-RX-API-DMAC7.html)
IL (1) IL185531A0 (cg-RX-API-DMAC7.html)
MX (1) MX2007010681A (cg-RX-API-DMAC7.html)
WO (1) WO2006096360A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7914814B2 (en) 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
AU2005235308B2 (en) 2004-04-19 2011-12-01 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
CA2666398C (en) 2006-10-17 2015-08-18 Ed Kisak Diclofenac gel
ES2316312B1 (es) * 2008-06-20 2010-02-08 Ignacio Umbert Millet Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas.
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
AU2009348470B2 (en) * 2009-06-24 2015-04-02 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
EP2445493A1 (en) * 2009-06-24 2012-05-02 Strategic Science & Technologies, LLC Topical composition containing naproxen
US12138268B2 (en) 2009-06-24 2024-11-12 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
AU2015203547B2 (en) * 2009-06-24 2017-05-18 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
JP2011106846A (ja) * 2009-11-13 2011-06-02 Hamamatsu Univ School Of Medicine 新規ｎｓａｉｄ潰瘍リスク判定方法
KR101141938B1 (ko) * 2010-01-22 2012-05-04 성균관대학교산학협력단 신규한 항생제 조성물 및 그람양성균의 치료 방법
JP2014504592A (ja) 2010-12-29 2014-02-24 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 勃起不全および他の適応症の処置
JP2014501283A (ja) 2010-12-29 2014-01-20 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー アレルギーおよび他の適応症の処置のためのシステムおよび方法
DK2704703T3 (da) 2011-05-03 2019-10-14 Aponia Laboratories Inc Transdermale sammensætninger af ibuprofen og fremgangsmåder til anvendelse deraf
EP3113849B1 (en) 2014-02-26 2019-06-12 Luma Therapeutics, Inc. Ultraviolet phototherapy apparatus
KR20180134856A (ko) 2016-02-09 2018-12-19 루마 세러퓨틱스 인코포레이티드 광선요법에 의해 건선을 치료하기 위한 방법, 조성물 및 장치
US20200230082A1 (en) * 2017-07-11 2020-07-23 University Of Miami Topical acetaminophen formulations for itch relief
US20230398060A1 (en) * 2020-05-19 2023-12-14 Mig Usa, Llc Topical compositions and methods for treating pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS596287B2 (ja) * 1980-11-28 1984-02-10 日東電工株式会社 医薬製剤
WO1987002891A1 (en) 1985-11-07 1987-05-21 Pfizer Inc. Compounds and method for the topical treatment of inflammation and pain
US5093133A (en) 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
US5639738A (en) 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
US5976566A (en) 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin

Also Published As

Publication number Publication date
AU2006220964A1 (en) 2006-09-14
CA2599968A1 (en) 2006-09-14
IL185531A0 (en) 2008-01-06
BRPI0608077A2 (pt) 2009-11-10
EP1858503B1 (en) 2013-09-04
EP1858503A1 (en) 2007-11-28
WO2006096360A1 (en) 2006-09-14
MX2007010681A (es) 2007-12-07
JP2008531693A (ja) 2008-08-14
KR20080008321A (ko) 2008-01-23

Similar Documents

Publication Publication Date Title
ES2437201T3 (es) Composiciones de geles tópicos
US20100158993A1 (en) Topical Gel Compositions
JP7698749B2 (ja) ｍＴＯＲ阻害剤の無水組成物およびその使用方法
CA2662434C (en) Topical nsaid compositions with increased solubility
JP2000501429A (ja) 局所治療用および化粧用製剤の組成物基剤
US20070280972A1 (en) Adhesive solid gel-forming formulations for dermal drug delivery
US12329748B2 (en) Anhydrous compositions of mTOR inhibitors and methods of use
JP2000143540A (ja) 非ステロイド系消炎鎮痛薬含有外用剤
US20050137164A1 (en) Diclofenac compositions for the treatment of skin disorders
WO2007102090A2 (en) Topical formulation
ZA200707357B (en) Detection of very virulent infectious bursal disease virus
AU2009273211B2 (en) Transdermal pharmaceutical compositions comprising danazol
CN101541321A (zh) 局部用组合物
AU2020216278B2 (en) Topical gel compositions of naproxen
RU2809702C2 (ru) Композиции напроксена для местного применения в форме геля
HK1119058A (en) Topical gels compositions
WO2024245894A1 (en) (4r)-3-(4-fluoro-2-hydroxyphenyl)-4-methyl-4,5-dihydro-1h-pyrazole-1-carboximidamide hydrochloride and dermal formulations thereof
JP6016085B2 (ja) 抗真菌外用組成物及び抗真菌外用組成物の適用方法
WO2018116190A1 (en) Topical sprayable compositions of ketorolac tromethamine